Erman Akkus posted on X:
“Liver transplantation for Transplant Oncology (TO) indications
TO indications: iCC, phCC, liver metastases from NET and CRC
- 5-years OS: 53,3%, 56,4%, 68,6% and 53,8%
- adequate 5-years survival rates
- May be considered in selected patients.”
Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.